The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl
Title:
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl
Author:
Dine, Jennifer L. O’Sullivan, Ciara C. Voeller, Donna Greer, Yoshimi E. Chavez, Kathryn J. Conway, Catherine M. Sinclair, Sarah Stone, Brandon Amiri-Kordestani, Laleh Merchant, Anand S. Hewitt, Stephen M. Steinberg, Seth M. Swain, Sandra M. Lipkowitz, Stanley